272 related articles for article (PubMed ID: 25336193)
1. Palliative radiotherapy in addition to self-expanding metal stent for improving dysphagia and survival in advanced oesophageal cancer (ROCS: Radiotherapy after Oesophageal Cancer Stenting): study protocol for a randomized controlled trial.
Adamson D; Blazeby J; Nelson A; Hurt C; Nixon L; Fitzgibbon J; Crosby T; Staffurth J; Evans M; Kelly NH; Cohen D; Griffiths G; Byrne A
Trials; 2014 Oct; 15():402. PubMed ID: 25336193
[TBL] [Abstract][Full Text] [Related]
2. Palliative radiotherapy combined with stent insertion to reduce recurrent dysphagia in oesophageal cancer patients: the ROCS RCT.
Adamson D; Blazeby J; Porter C; Hurt C; Griffiths G; Nelson A; Sewell B; Jones M; Svobodova M; Fitzsimmons D; Nixon L; Fitzgibbon J; Thomas S; Millin A; Crosby T; Staffurth J; Byrne A
Health Technol Assess; 2021 May; 25(31):1-144. PubMed ID: 34042566
[TBL] [Abstract][Full Text] [Related]
3. Palliative radiotherapy after oesophageal cancer stenting (ROCS): a multicentre, open-label, phase 3 randomised controlled trial.
Adamson D; Byrne A; Porter C; Blazeby J; Griffiths G; Nelson A; Sewell B; Jones M; Svobodova M; Fitzsimmons D; Nixon L; Fitzgibbon J; Thomas S; Millin A; Crosby T; Staffurth J; Hurt C
Lancet Gastroenterol Hepatol; 2021 Apr; 6(4):292-303. PubMed ID: 33610215
[TBL] [Abstract][Full Text] [Related]
4. Interventions for dysphagia in oesophageal cancer.
Dai Y; Li C; Xie Y; Liu X; Zhang J; Zhou J; Pan X; Yang S
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD005048. PubMed ID: 25354795
[TBL] [Abstract][Full Text] [Related]
5. WITHDRAWN: Interventions for dysphagia in oesophageal cancer.
Sreedharan A; Harris K; Crellin A; Forman D; Everett SM
Cochrane Database Syst Rev; 2011 Feb; (2):CD005048. PubMed ID: 21328271
[TBL] [Abstract][Full Text] [Related]
6. Interventions for dysphagia in oesophageal cancer.
Sreedharan A; Harris K; Crellin A; Forman D; Everett SM
Cochrane Database Syst Rev; 2009 Oct; (4):CD005048. PubMed ID: 19821338
[TBL] [Abstract][Full Text] [Related]
7. Palliative stenting for relief of dysphagia in patients with inoperable esophageal cancer: impact on quality of life.
Madhusudhan C; Saluja SS; Pal S; Ahuja V; Saran P; Dash NR; Sahni P; Chattopadhyay TK
Dis Esophagus; 2009; 22(4):331-6. PubMed ID: 19473211
[TBL] [Abstract][Full Text] [Related]
8. Economic analysis of esophageal stenting for management of malignant dysphagia.
Rao C; Haycock A; Zacharakis E; Krasopoulos G; Yakoub D; Protopapas A; Darzi A; Hanna GB; Athanasiou T
Dis Esophagus; 2009; 22(4):337-47. PubMed ID: 19207559
[TBL] [Abstract][Full Text] [Related]
9. Palliative chemoradiotherapy versus radiotherapy alone for dysphagia in advanced oesophageal cancer: a multicentre randomised controlled trial (TROG 03.01).
Penniment MG; De Ieso PB; Harvey JA; Stephens S; Au HJ; O'Callaghan CJ; Kneebone A; Ngan SY; Ward IG; Roy R; Smith JG; Nijjar T; Biagi JJ; Mulroy LA; Wong R;
Lancet Gastroenterol Hepatol; 2018 Feb; 3(2):114-124. PubMed ID: 29248399
[TBL] [Abstract][Full Text] [Related]
10. Palliative stenting with or without radiotherapy for inoperable esophageal carcinoma: a randomized trial.
Javed A; Pal S; Dash NR; Ahuja V; Mohanti BK; Vishnubhatla S; Sahni P; Chattopadhyay TK
J Gastrointest Cancer; 2012 Mar; 43(1):63-9. PubMed ID: 20835926
[TBL] [Abstract][Full Text] [Related]
11. Combined stent insertion and single high-dose brachytherapy in patients with advanced esophageal cancer--results of a prospective safety study.
Bergquist H; Johnsson E; Nyman J; Rylander H; Hammerlid E; Friesland S; Ejnell H; Lundell L; Ruth M
Dis Esophagus; 2012 Jul; 25(5):410-5. PubMed ID: 21899654
[TBL] [Abstract][Full Text] [Related]
12. The cost effectiveness of metal oesophageal stenting in malignant disease compared with conventional therapy.
Nicholson DA; Haycox A; Kay CL; Rate A; Attwood S; Bancewicz J
Clin Radiol; 1999 Apr; 54(4):212-5. PubMed ID: 10210338
[TBL] [Abstract][Full Text] [Related]
13. Health economic evaluation of stent or endoluminal brachytherapy as a palliative strategy in patients with incurable cancer of the oesophagus or gastro-oesophageal junction: results of a randomized clinical trial.
Wenger U; Johnsson E; Bergquist H; Nyman J; Ejnell H; Lagergren J; Ruth M; Lundell L
Eur J Gastroenterol Hepatol; 2005 Dec; 17(12):1369-77. PubMed ID: 16292092
[TBL] [Abstract][Full Text] [Related]
14. A pragmatic randomised controlled trial of the cost-effectiveness of palliative therapies for patients with inoperable oesophageal cancer.
Shenfine J; McNamee P; Steen N; Bond J; Griffin SM
Health Technol Assess; 2005 Feb; 9(5):iii, 1-121. PubMed ID: 15717937
[TBL] [Abstract][Full Text] [Related]
15. Self-expanding metal stents versus plastic prostheses in the palliation of malignant dysphagia: long-term outcome of 153 consecutive patients.
Eickhoff A; Knoll M; Jakobs R; Weickert U; Hartmann D; Schilling D; Eickhoff JC; Riemann JF
J Clin Gastroenterol; 2005; 39(10):877-85. PubMed ID: 16208111
[TBL] [Abstract][Full Text] [Related]
16. Outcome of palliative esophageal stenting for malignant dysphagia: a retrospective analysis.
Burstow M; Kelly T; Panchani S; Khan IM; Meek D; Memon B; Memon MA
Dis Esophagus; 2009; 22(6):519-25. PubMed ID: 19302213
[TBL] [Abstract][Full Text] [Related]
17. Self-expanding metal stents in palliation of malignant dysphagia: outcome of 124 Egyptian patients.
Elsharkawy AA; El-Geidie AA
Eur Arch Otorhinolaryngol; 2010 Jul; 267(7):1123-7. PubMed ID: 20069308
[TBL] [Abstract][Full Text] [Related]
18. [Palliative treatment of esophageal cancer with dysphagia: more favourable outcome from single-dose internal brachytherapy than from the placement of a self-expanding stent; a multicenter randomised study].
Homs MY; Steyerberg EW; Eijkenboom WM; Tilanus HW; Stalpers LJ; Bartelsman JF; van Lanschot JJ; Wijrdeman HK; Mulder CJ; Reinders JG; Boot H; Aleman BM; Kuipers EJ; Siersema PD
Ned Tijdschr Geneeskd; 2005 Dec; 149(50):2800-6. PubMed ID: 16385833
[TBL] [Abstract][Full Text] [Related]
19. Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial.
Homs MY; Steyerberg EW; Eijkenboom WM; Tilanus HW; Stalpers LJ; Bartelsman JF; van Lanschot JJ; Wijrdeman HK; Mulder CJ; Reinders JG; Boot H; Aleman BM; Kuipers EJ; Siersema PD
Lancet; 2004 Oct 23-29; 364(9444):1497-504. PubMed ID: 15500894
[TBL] [Abstract][Full Text] [Related]
20. Stent insertion or endoluminal brachytherapy as palliation of patients with advanced cancer of the esophagus and gastroesophageal junction. Results of a randomized, controlled clinical trial.
Bergquist H; Wenger U; Johnsson E; Nyman J; Ejnell H; Hammerlid E; Lundell L; Ruth M
Dis Esophagus; 2005; 18(3):131-9. PubMed ID: 16045572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]